Subscribe to RSS
DOI: 10.1055/a-1609-0722
Prävention des akuten Nierenversagens
Prevention of acute kidney injury
Das akute Nierenversagen trägt wesentlich zu Morbidität und Mortalität hospitalisierter Patienten bei und gehört zu den häufigsten Komplikationen auf der Intensivstation. Dieser Beitrag gibt einen Überblick über Risiko-Scores zur Identifizierung gefährdeter Patienten und über empfohlene Maßnahmenbündel, um das Auftreten und Voranschreiten eines akuten Nierenversagens zu verhindern.
Abstract
Acute kidney injury contributes significantly to morbidity and mortality in hospitalized patients and is a common complication in the intensive care unit. Identification of patients at risk, elimination of modifiable risk factors and initiation of recommended preventive measures are the main cornerstones to prevent the onset and progression of acute kidney injury. Clinical and biomarker-based risk scores can help assess AKI-risk in specific patient populations. To date, there is no approved clinically effective drug to prevent AKI. Current guidelines suggest preventive care bundles that include optimizing volume status and renal perfusion by improving mean arterial pressure and using vasopressors, mainly norepinephrine. In addition, avoidance of volume overload and the targeted use of diuretics to achieve euvolemia are recommended. Nephrotoxic drugs require a critical risk-benefit assessment and therapeutic drug monitoring when appropriate. Contrast imaging should not be withheld from patients at risk of AKI when indicated but contrast medium should be limited to the smallest possible volume. Finally, recommendations include maintenance of normoglycemia and other measures to optimize organ function in specific patient populations.
Publication History
Article published online:
28 February 2022
© 2022. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
Literatur
- 1 Kidney Disease: Improving Global Outcome(KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl 2012; 2: 1-138
- 2 Joannidis M, Druml W, Forni LG. et al. Prevention of acute kidney injury and protection of renal function in the intensive care unit: update 2017 : Expert opinion of the Working Group on Prevention, AKI section, European Society of Intensive Care Medicine. Intensive Care Med 2017; 43 (06) 730-749
- 3 Kullmar M, Weiss R, Ostermann M. et al. A Multinational Observational Study Exploring Adherence With the Kidney Disease: Improving Global Outcomes Recommendations for Prevention of Acute Kidney Injury After Cardiac Surgery. Anesth Analg 2020; 130 (04) 910-916
- 4 Malhotra R, Kashani KB, Macedo E. et al. A risk prediction score for acute kidney injury in the intensive care unit. Nephrol Dial Transplant 2017; 32 (05) 814-822
- 5 Ostermann M, Zarbock A, Goldstein S. et al. Recommendations on Acute Kidney Injury Biomarkers From the Acute Disease Quality Initiative Consensus Conference: A Consensus Statement. JAMA Netw Open 2020; 3 (10) e2019209
- 6 Zarbock A, Kullmar M, Ostermann M. et al. Prevention of Cardiac Surgery-Associated Acute Kidney Injury by Implementing the KDIGO Guidelines in High-Risk Patients Identified by Biomarkers: The PrevAKI-Multicenter Randomized Controlled Trial. Anesth Analg 2021; 133 (02) 292-302
- 7 Gocze I, Jauch D, Gotz M. et al. Biomarker-guided Intervention to Prevent Acute Kidney Injury After Major Surgery: The Prospective Randomized BigpAK Study. Ann Surg 2018; 267 (06) 1013-1020
- 8 Vijayan A, Faubel S, Askenazi DJ. et al. Clinical Use of the Urine Biomarker [TIMP-2] × [IGFBP7] for Acute Kidney Injury Risk Assessment. Am J Kidney Dis 2016; 68 (01) 19-28
- 9 Semler MW, Self WH, Rice TW. Balanced Crystalloids versus Saline in Critically Ill Adults. N Engl J Med 2018; 378 (20) 1951
- 10 Cavallaro F, Sandroni C, Marano C. et al. Diagnostic accuracy of passive leg raising for prediction of fluid responsiveness in adults: systematic review and meta-analysis of clinical studies. Intensive Care Med 2010; 36 (09) 1475-1483
- 11 Wiedemann HP, Wheeler AP, Bernard GR. National Heart L, Blood Institute Acute Respiratory Distress Syndrome Clinical Trials N. et al. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 2006; 354 (24) 2564-2575
- 12 Joannidis M, Klein SJ, John S. et al. Prevention of acute kidney injury in critically ill patients. Recommendations from the renal section of the DGIIN, OGIAIN and DIVI. Med Klin-Intensivmed 2018; 113 (05) 358-369
- 13 Mehran R, Aymong ED, Nikolsky E. et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 2004; 44 (07) 1393-1399
- 14 Gurm HS, Dixon SR, Smith DE. et al. Renal function-based contrast dosing to define safe limits of radiographic contrast media in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 2011; 58 (09) 907-914
- 15 Thakar CV, Arrigain S, Worley S. et al. A clinical score to predict acute renal failure after cardiac surgery. J Am Soc Nephrol 2005; 16 (01) 162-168
- 16 Meersch M, Schmidt C, Hoffmeier A. et al. Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial. Intensive Care Med 2017; 43 (11) 1551-1561
- 17 Park S, Cho H, Park S. et al. Simple Postoperative AKI Risk (SPARK) Classification before Noncardiac Surgery: A Prediction Index Development Study with External Validation. J Am Soc Nephrol 2019; 30 (01) 170-181
- 18 Basu RK, Wang Y, Wong HR. et al. Incorporation of biomarkers with the renal angina index for prediction of severe AKI in critically ill children. Clin J Am Soc Nephrol 2014; 9 (04) 654-662
- 19 Bellomo R, Kellum JA, Ronco C. et al. Acute kidney injury in sepsis. Intensive Care Med 2017; 43 (06) 816-828
- 20 Hjortrup PB, Haase N, Bundgaard H. et al. Restricting volumes of resuscitation fluid in adults with septic shock after initial management: the CLASSIC randomised, parallel-group, multicentre feasibility trial. Intensive Care Med 2016; 42 (11) 1695-1705